Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,547 public trials 2,851 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML

NCT06191263

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Centre Hospitalier Universitaire Grenoble Alpes Grenoble, France
  • Centre Hospitalier Le Mans Le Mans, France
  • Centre Hospitalier Universitaire De Lille Lille, France
  • Institut Paoli-Calmettes Marseille, France
View all 37 locations
View Trial Details
Recruiting

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

NCT07422480

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +3 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope - Comprehensive Cancer Center (CCC) Duarte, California, United States
  • Providence Medical Group Santa Rosa, California, United States
  • University of Miami Miami, Florida, United States
View all 162 locations
View Trial Details
Recruiting

A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany

NCT06695897

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
Locations
  • Investigational Site Number: 0000001 Dachau, Bavaria, Germany
  • Investigational Site Number: 0000009 Aschaffenburg, Bavaria, Germany
  • Investigational Site Number: 0000014 Augsburg, Bavaria, Germany
  • Investigational Site Number: 0000012 Erlangen, Bavaria, Germany
View all 15 locations
View Trial Details
Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

NCT07221500

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +16 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Institute Denver, Colorado, United States
  • University of Miami Coral Gables, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 40 locations
View Trial Details

Related conditions